MSLN and ovarian carcinoma: Our SQ RT–PCR and QRT RT–PCR analyses confirmed earlier reports (Chang and Pastan, 1996; Schaner et al, 2003) that mesothelin was expressed in cancerous tissues of ovarian carcinomas, suggesting that mesothelin could be an ideal marker for cancer diagnosis and target-based therapy.